| Financial Year |
March 31 2023 |
| Monetary Funds |
418,431,222.38 |
| Held-for-trading Financial Assets |
314,542,942.79 |
| Notes Receivable |
85,500.00 |
| Accounts Receivable |
147,053,109.62 |
| Advances to Suppliers |
68,244,188.03 |
| Other Receivables |
38,820,581.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
87,473,441.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,854,495.26 |
| Total Current Assets |
1,079,505,480.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,126,309,096.74 |
| Investment Properties |
834,204,750.00 |
| Fixed Assetes |
296,726,485.36 |
| Under-construction Projects |
163,791,062.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,598,123.98 |
| R&D expenses |
10,430,143.87 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,593,512.20 |
| Deferred Income Tax Assets |
19,869,737.12 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,904,744,954.53 |
| Total Assets |
4,984,250,435.15 |
| Short-Term Loans |
15,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
65,942,044.89 |
| Accounts Received In Advance |
9,778,504.22 |
| Employee Compensation Payable |
23,709,949.67 |
| Taxes Payable |
42,172,520.87 |
| Interest Payable |
-- |
| Dividend Payable |
1,051,308.73 |
| Other payables |
242,746,183.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
844,602.08 |
| Other Current Liabilities |
5,515,454.07 |
| Sub-Total of Current Liabilities |
441,079,036.97 |
| Long-term Loans |
11,865,569.58 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
441,921,156.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
453,786,726.22 |
| Total Liabilities |
894,865,763.19 |
| Paid-In Capital(Or Share Stock) |
1,207,056,692.00 |
| Capital Surplus |
420,286,816.76 |
| Surplus Reserve |
540,501,338.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
735,896,139.21 |
| Minority Stockholder's Interest |
175,758,569.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,913,626,102.91 |
| Owner's Equity（Stockholder's Equity） |
4,089,384,671.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,984,250,435.15 |
